Stockreport

Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update [Financial Post (Toronto, Ontario, Canada)]

Arbutus Biopharma Corporation  (ABUS) 
Last arbutus biopharma corporation earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.arbutusbio.com/node/5806
PDF Plans to initiate a third Phase 2a clinical trial with imdusiran in first half of 2024 Article content Claim Construction for Moderna LNP litigation occurred on Feb [Read more]